13 May 2020 : Case report
A Paralyzing Case of Myalgias
Challenging differential diagnosis, Adverse events of drug therapy
Camille Simard1EF*, Amélie Paquin2EF, Blair Carl Schwartz13EFGDOI: 10.12659/AJCR.922568
Am J Case Rep 2020; 21:e922568
Abstract
BACKGROUND: Myalgia, which describes muscle pain or soreness, is a common presenting complaint encountered in the Emergency Department, in inpatient settings and in outpatient settings. Its differential diagnosis is broad and includes benign as well as more serious clinical entities. Some of the common causes of myalgias include viral infections, strenuous exercise, and medications. Succinylcholine is a well-known neuromuscular blockade agent that is frequently used for rapid sequence intubation and short surgeries.
CASE REPORT: We present the case of a 70-year-old male who presented to the Emergency Department with a chief complaint of acute, severe onset diffuse myalgia leading to the inability to mobilize. He was being investigated for recent onset generalized lymphadenopathy and had undergone a diagnostic lymph node biopsy under general anesthesia 2 days prior to his presentation. He was diagnosed with presumed succinylcholine-induced myalgias after other etiologies were deemed less likely with thorough history, physical examination, and laboratory investigations. Succinylcholine binds nicotinic acetylcholine receptors of the neuromuscular junction and produces prolonged depolarization during which activation of the muscle is blocked. Initial depolarization of the neuromuscular junction induces hectic fasciculation of the muscle fibers, which in turn may be responsible for the occurrence of post-operative myalgias (POM). This entity can be severe and debilitating and is self-limited.
CONCLUSIONS: Succinylcholine remains a commonly used agent in anesthesia and succinylcholine-induced myalgia should remain in the differential diagnosis of acute, non-inflammatory myalgia. Its recognition can help avoid unwarranted, possibly invasive investigations and their associated additional healthcare costs.
Keywords: Drug-Related Side Effects and Adverse Reactions, Myalgia, Succinylcholine, Anesthesia, General, Neuromuscular Depolarizing Agents, Paralysis
In Press
02 Apr 2024 : Case report
Langerhans Cell Histiocytosis in Sphenoid Sinus: Uncommon Bone InvolvementAm J Case Rep In Press; DOI: 10.12659/AJCR.942681
03 Apr 2024 : Case report
A Rare Case of Congenital Nephrogenic Diabetes Insipidus Associated with Aquaporin 2 Gene Mutation and Subs...Am J Case Rep In Press; DOI: 10.12659/AJCR.943597
03 Apr 2024 : Case report
Epigastric Pain and Dysphagia in a 36-Year-Old Man Due to Primary Esophageal Small Cell CarcinomaAm J Case Rep In Press; DOI: 10.12659/AJCR.943392
04 Apr 2024 : Case report
Duodenal Soft Tissue Sarcoma with GLI1 Gene Rearrangement: A Case Report and Literature ReviewAm J Case Rep In Press; DOI: 10.12659/AJCR.943271
Most Viewed Current Articles
07 Mar 2024 : Case report
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
23 Feb 2022 : Case report
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250